期刊文献+

MicroRNA与胰腺癌的研究进展 被引量:1

下载PDF
导出
摘要 胰腺癌(pancreaticcarcinoma,PC)不仅是消化系统较为常见的恶性肿瘤,更是消化系统肿瘤中恶性程度较高的肿瘤之一。由于PC早期临床表现不典型而难以被发现,多数患者就诊时已为癌症晚期。对于PC目前仍然缺乏有效的药物干预及其他治疗手段,早期手术是根治PC的唯一治疗方法。如何提高PC高危人群早期筛查确诊率、提高癌变组织药敏性及改善PC晚期患者生存质量是PC研究中的重点及难点。
出处 《华南国防医学杂志》 CAS 2013年第4期284-286,共3页 Military Medical Journal of South China
基金 广东省科技计划项目(2011B031800317) 广东省大学生创新实验项目(1057212046)
  • 相关文献

参考文献5

二级参考文献105

  • 1张克君,高焱明.核因子-κB p65在肝炎相关性肝细胞癌中的表达及意义[J].中国癌症杂志,2005,15(1):12-15. 被引量:5
  • 2唐瑞峰,王曙霞,张风瑞,王顺祥,彭利,张萌,肖燕.TNF-α和低氧对胰腺癌细胞表达VEGF-A、C的调节[J].中国肿瘤临床,2005,32(15):852-855. 被引量:2
  • 3唐瑞峰,王曙霞,彭利,王顺祥,张萌,肖燕,张风瑞.细胞因子和低氧对胰腺癌细胞表达血管内皮生长因子A、C的调节[J].肿瘤,2007,27(1):30-33. 被引量:2
  • 4Li D, Xie K, Wolff R and Abbruzzese JL. Pancreatic cancer. Lancet 2004, 363: 1049–1057.
  • 5Postier RG. The challenge of pancreatic cancer. Am J Surg 2003, 186: 579–582.
  • 6Esquela-Kerscher A and Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 2006, 6: 259–269.
  • 7Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6: 857–866.
  • 8Sevignani C, Calin GA, Siracusa LD and Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 2006, 17: 189–202.
  • 9Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A and Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103: 2257–2261.
  • 10Ciafre' SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G and Negrini M, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005, 334: 1351–1358.

共引文献28

同被引文献30

  • 1徐杰,彭勇,任建政,李正华,纪涛,冯晨.螺旋CT增强双期扫描诊断胰腺癌18例[J].武警医学,2007,18(9):690-691. 被引量:1
  • 2Sarles H, Sarle J C, Muratore R, et al. Chronic inflam- matory sclerosis of the pancreas an autonomous pan- creatic disease? [J]. Am J Dig Dis, 1961,6:688-698.
  • 3Yoshida K, Toki F, Takeuchi T, et al. Chronic pancrea- titis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis [ J ]. Dig Dis Sci,1995,40 ( 7 ) : 1561-1568.
  • 4Notohara K, Burgart L J, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic in- filtration: clinicopathologic features of 35 cases[ J]. Am J Surg Pathol, 2003,27(8) :1119-1127.
  • 5Sah R P, Chari S T, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 au- toimmune panereatitis [ J ]. Gastroenterology, 2010, 139 (1) :140-148.
  • 6Sugumar A, Kloppel G, Chari S T. Autoimmune pancrea- titis: pathologic subtypes and their implications for its di- agnosis[ J ]. Am J Gastroenterol, 2009, 104 ( 9 ) : 2308- 2310.
  • 7Kamisawa T, Funata N, Hayashi Y, et al. A new clini- copathological entity of IgG4-related autoimmune disease [ J ]. J Gastroenterol, 2003,38 ( 10 ) : 982-984.
  • 8Takahashi H, Yamamoto M, Suzuki C, et al. The birth- day of a new syndrome : IgG4-related diseases constitute a clinical entity [ J ]. Autoimmun Rev, 2010,9 ( 9 ) : 591 - 594.
  • 9Zhang L, Smyrk T C. Autoimmune pancreatitis and IgG4- related systemic diseases [ J ]. Int J Clin Exp Pathol, 2010,3 ( 5 ) :491-504.
  • 10Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive muhiorgan lymphoprolifera- tive syndrome : analysis of 64 cases of IgG4-related disor- ders[J]. Ann Rheum Dis, 2009,68(8) :1310-1315.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部